Researchers found no significant differences in surgical outcomes or follow-up between housed and unhoused patients with ...

Mice with a version of osteoarthritis experienced symptom relief after expression of a protein targeting a stem-cell receptor ...

CHICO, Calif. - Arthritis is a leading reason for euthanizing older pets, but a new treatment called Synovetin OA is offering hope to pet owners. This breakthrough is promising to change the lives of ...

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Partnership expected to advance 5x30 strategy by increasing ZILRETTA sales calls and extensively expanding patient access ...

Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Johnson & Johnson is partnering with Pacira BioSciences for osteoarthritis of the knee, according to a July 22 news release. The agreement adds Zilretta, an injectable osteoarthritis treatment, to ...

BOSTON: Elenagen ™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown ...

A five-month trial saw physiotherapists triage and treat more than 1200 orthopaedic patients in six regions, each of whom had ...

The shoulder has a wide range of motion making it the most mobile joint. But because of this flexibility, it's not very stable and easily injured.